News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eidogen-Sertanty And Kalypsys, Inc. Establish Drug Discovery Collaboration



12/14/2005 11:55:58 AM

SAN DIEGO--(BUSINESS WIRE)--Dec. 14, 2005--Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced that they have established a collaboration with San Diego-based Kalypsys, Inc., focused on the discovery of novel small molecules for anti-inflammatory indications.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES